Dennis Bigg
Impact in
- Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents
- Organic Chemistry top 5%
- Synthesis and biological activity
- Synthetic Organic Chemistry Methods
Papers in
-
- Bioactive Compounds and Antitumor Agents 4
-
- Chemical Synthesis and Reactions 4
- Chemical synthesis and alkaloids 4
- Co-authors
- Olivier LavergneGuy BertrandLaurence Lesueur‐GinotDanièle DemarquayMarion HuchetHélène CoulombPhilip G. KasprzykAlain Rolland
- Journals
- Bioorganic & Medicinal Chemistry Letters (12 papers)Synthesis (6 papers)The Journal of Organic Chemistry (4 papers)Journal of Medicinal Chemistry (3 papers)Annals of the New York Academy of Sciences (3 papers)
- Partner nations
- FranceUnited KingdomSpain
In The Last Decade
Dennis Bigg
47 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 88
- Toxicology 244
- Organic Chemistry 507
- Oncology 354
- Molecular Biology 863
- Biochemistry 52
Countries citing papers authored by Dennis Bigg
This map shows the geographic impact of Dennis Bigg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Bigg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Bigg more than expected).
Fields of papers citing papers by Dennis Bigg
This network shows the impact of papers produced by Dennis Bigg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Bigg. The network helps show where Dennis Bigg may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dennis Bigg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 4 | |
| 2 | 2008 | 42 | |
| 3 | 2008 | 19 | |
| 4 | A novel synthetic CDC25 phosphatase inhibitor inhibits human cancer growth in vitro and in vivo | 2007 | 1 |
| 5 | 2007 | 63 | |
| 6 | 2006 | 11 | |
| 7 | 2005 | 6 | |
| 8 | 2004 | 9 | |
| 9 | 2004 | 12 | |
| 10 | 2003 | 59 | |
| 11 | 2003 | 14 | |
| 12 | 2002 | 15 | |
| 13 | 2001 | 24 | |
| 14 | Unusual potency of BN 80915, a novel fluorinated E-ring modified camptothecin, toward human colon carcinoma cells. | 2001 | 31 |
| 15 | 2000 | 13 | |
| 16 | 2000 | 20 | |
| 17 | 1999 | 40 | |
| 18 | 1993 | 46 | |
| 19 | 1992 | 12 | |
| 20 | 1991 | 18 |
About Dennis Bigg
Dennis Bigg is a scholar working on Toxicology, Organic Chemistry, Oncology, Molecular Biology and Pharmacology, having authored 47 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (13 papers), Neutropenia and Cancer Infections (10 papers), Lung Cancer Research Studies (7 papers), Bioactive Compounds and Antitumor Agents (4 papers), Chemical Synthesis and Analysis (4 papers), Phenothiazines and Benzothiazines Synthesis and Activities (4 papers), Chemical Synthesis and Reactions (4 papers) and Chemical synthesis and alkaloids (4 papers). The work is most often cited by research in Toxicology (244 citations), Organic Chemistry (507 citations), Oncology (354 citations), Molecular Biology (863 citations) and Biochemistry (52 citations). Dennis Bigg has collaborated with scholars based in France, United Kingdom and Spain. Frequent co-authors include Olivier Lavergne, Guy Bertrand, Laurence Lesueur‐Ginot, Danièle Demarquay, Marion Huchet, Hélène Coulomb, Philip G. Kasprzyk, Alain Rolland, Marie-Odile Contour-Galcéra and José Camara. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Synthesis, The Journal of Organic Chemistry, Journal of Medicinal Chemistry and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.